First Page | Document Content | |
---|---|---|
Date: 2016-01-26 15:03:13Gilead Sciences Chemistry HIV/AIDS Medicine Organofluorides Specialty drugs Prodrugs Prevention of HIV/AIDS AIDS Healthcare Foundation Tenofovir alafenamide Tenofovir disoproxil Fixed-dose combination | Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar NoAdd to Reading ListSource URL: www.aidshealth.orgDownload Document from Source WebsiteFile Size: 985,53 KBShare Document on Facebook |
AIDS InfoNetwww.aidsinfonet.org Fact Sheet Number 478 Biktarvy (bictegravir + emtricitabine + tenofovir alafenamide)DocID: 1ucKl - View Document | |
Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar NoDocID: 1rqYi - View Document | |
March 4, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:DocID: 1rdax - View Document | |
GENERAL CONFORMITY CERTIFICATE This is an electronically controlled document. User is responsible for verifying and using the effective version. Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that basDocID: 1pCJo - View Document | |
Microsoft Word - GOCER-028.docxDocID: 1pkag - View Document |